• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Hyperthermic intraperitoneal perfusion chemotherapy--views on the observed variability in oxaliplatin pharmacokinetics.

作者信息

Srinivas Nuggehally R

出版信息

Eur J Clin Pharmacol. 2009 Mar;65(3):321-2. doi: 10.1007/s00228-008-0585-4. Epub 2008 Nov 15.

DOI:10.1007/s00228-008-0585-4
PMID:19011850
Abstract
摘要

相似文献

1
Hyperthermic intraperitoneal perfusion chemotherapy--views on the observed variability in oxaliplatin pharmacokinetics.
Eur J Clin Pharmacol. 2009 Mar;65(3):321-2. doi: 10.1007/s00228-008-0585-4. Epub 2008 Nov 15.
2
Pharmacokinetics of heated intraperitoneal oxaliplatin.腹腔内热灌注奥沙利铂的药代动力学
Cancer Chemother Pharmacol. 2008 Sep;62(4):679-83. doi: 10.1007/s00280-007-0654-x. Epub 2007 Dec 15.
3
Increased tissue diffusion of oxaliplatin during laparoscopically assisted versus open heated intraoperative intraperitoneal chemotherapy (HIPEC).与开腹热灌注化疗（HIPEC）相比，腹腔镜辅助热灌注化疗期间奥沙利铂的组织扩散增加。
Ann Surg Oncol. 2008 Dec;15(12):3623-4. doi: 10.1245/s10434-008-0115-8. Epub 2008 Aug 26.
4
HIPEC with oxaliplatin in the treatment of peritoneal carcinomatosis of colorectal origin.奥沙利铂腹腔热灌注化疗治疗结直肠癌源性腹膜癌病
Cancer Treat Res. 2007;134:303-18. doi: 10.1007/978-0-387-48993-3_19.
5
Population pharmacokinetics of peritoneal, plasma ultrafiltrated and protein-bound oxaliplatin concentrations in patients with disseminated peritoneal cancer after intraperitoneal hyperthermic chemoperfusion of oxaliplatin following cytoreductive surgery: correlation between oxaliplatin exposure and thrombocytopenia.患者接受细胞减灭术后腹腔内加温化疗奥沙利铂后，散发性腹膜癌患者腹腔、血浆超滤和蛋白结合奥沙利铂浓度的群体药代动力学：奥沙利铂暴露与血小板减少症的相关性。
Cancer Chemother Pharmacol. 2014 Sep;74(3):571-82. doi: 10.1007/s00280-014-2525-6. Epub 2014 Jul 23.
6
Rapid correction of severe hyperglycaemia during hyperthermic intraperitoneal chemoperfusion with oxaliplatin.
Acta Chir Belg. 2009 Mar-Apr;109(2):256-9. doi: 10.1080/00015458.2009.11680420.
7
Pharmacokinetic and pharmacodynamic analysis of hyperthermic intraperitoneal oxaliplatin-induced neutropenia in subjects with peritoneal carcinomatosis.腹腔内高温奥沙利铂引起腹腔转移瘤患者中性粒细胞减少的药代动力学和药效学分析。
AAPS J. 2011 Mar;13(1):72-82. doi: 10.1208/s12248-010-9249-2. Epub 2011 Jan 6.
8
Lessons learned from hyponatremia associated with hyperthermic intraperitoneal chemoperfusion with oxaliplatin.
Perit Dial Int. 2008 Jan-Feb;28(1):32-4.
9
Rationale for heating oxaliplatin for the intraperitoneal treatment of peritoneal carcinomatosis: a study of the effect of heat on intraperitoneal oxaliplatin using a murine model.加热奥沙利铂用于腹腔内治疗腹膜癌转移的理由：使用小鼠模型研究热对腹腔内奥沙利铂的影响。
Ann Surg. 2011 Jul;254(1):138-44. doi: 10.1097/SLA.0b013e3182193143.
10
A phase I trial of oxaliplatin for intraperitoneal hyperthermic chemoperfusion for the treatment of peritoneal surface dissemination from colorectal and appendiceal cancers.一项关于奥沙利铂用于腹腔热灌注化疗治疗结直肠癌和阑尾癌腹膜表面播散的I期试验。
Ann Surg Oncol. 2008 Aug;15(8):2137-45. doi: 10.1245/s10434-008-9967-1. Epub 2008 May 21.

本文引用的文献

1
Significance of organic cation transporter 3 (SLC22A3) expression for the cytotoxic effect of oxaliplatin in colorectal cancer.有机阳离子转运体3（SLC22A3）表达对奥沙利铂在结直肠癌中细胞毒性作用的意义
Drug Metab Dispos. 2008 Nov;36(11):2299-306. doi: 10.1124/dmd.108.023168. Epub 2008 Aug 18.
2
Systemic exposure of the parent drug oxaliplatin during hyperthermic intraperitoneal perfusion.奥沙利铂母体药物在腹腔热灌注期间的全身暴露情况。
Eur J Clin Pharmacol. 2008 Sep;64(9):907-11. doi: 10.1007/s00228-008-0511-9. Epub 2008 Jun 18.
3
Pharmacokinetics of heated intraperitoneal oxaliplatin.
腹腔内热灌注奥沙利铂的药代动力学
Cancer Chemother Pharmacol. 2008 Sep;62(4):679-83. doi: 10.1007/s00280-007-0654-x. Epub 2007 Dec 15.
4
Swedish experience with peritonectomy and HIPEC. HIPEC in peritoneal carcinomatosis.瑞典腹膜切除术和腹腔内热灌注化疗的经验。腹腔内热灌注化疗用于治疗腹膜癌病。
Ann Surg Oncol. 2008 Mar;15(3):745-53. doi: 10.1245/s10434-007-9700-5. Epub 2007 Dec 5.
5
Population pharmacokinetics of gemcitabine and its metabolite in patients with cancer: effect of oxaliplatin and infusion rate.吉西他滨及其代谢产物在癌症患者中的群体药代动力学：奥沙利铂和输注速率的影响。
Br J Clin Pharmacol. 2008 Mar;65(3):326-33. doi: 10.1111/j.1365-2125.2007.03040.x. Epub 2007 Oct 24.
6
Differential contribution of organic cation transporters, OCT2 and MATE1, in platinum agent-induced nephrotoxicity.有机阳离子转运体OCT2和MATE1在铂类药物诱导的肾毒性中的不同作用。
Biochem Pharmacol. 2007 Aug 1;74(3):477-87. doi: 10.1016/j.bcp.2007.03.004. Epub 2007 Mar 12.
7
Cisplatin and oxaliplatin, but not carboplatin and nedaplatin, are substrates for human organic cation transporters (SLC22A1-3 and multidrug and toxin extrusion family).顺铂和奥沙利铂是人类有机阳离子转运体（SLC22A1 - 3以及多药和毒素外排家族）的底物，但卡铂和奈达铂不是。
J Pharmacol Exp Ther. 2006 Nov;319(2):879-86. doi: 10.1124/jpet.106.110346. Epub 2006 Aug 16.
8
Short-time infusion of oxaliplatin in combination with capecitabine (XELOX30) as second-line therapy in patients with advanced colorectal cancer after failure to irinotecan and 5-fluorouracil.奥沙利铂与卡培他滨联合短时间输注（XELOX30）作为伊立替康和5-氟尿嘧啶治疗失败后的晚期结直肠癌患者的二线治疗方案。
Ann Oncol. 2006 Feb;17(2):252-8. doi: 10.1093/annonc/mdj060. Epub 2005 Nov 15.
9
Continuous infusion of oxaliplatin plus chronomodulated capecitabine in 5-fluorouracil- and irinotecan-resistant advanced colorectal cancer patients.奥沙利铂持续输注联合时辰调节卡培他滨用于对氟尿嘧啶和伊立替康耐药的晚期结直肠癌患者。
Oncology. 2005;69(1):27-34. doi: 10.1159/000087285. Epub 2005 Jul 28.
10
Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy.通过完全切除和腹腔内化疗对结直肠癌引起的腹膜癌进行根治性治疗。
Cancer. 2001 Jul 1;92(1):71-6. doi: 10.1002/1097-0142(20010701)92:1<71::aid-cncr1293>3.0.co;2-9.